← Back to headlines
AbbVie's Dividend Strategy Outperforms Pfizer's for Sustainable Growth
An analysis argues that AbbVie's dividend strategy offers more sustainable growth compared to Pfizer's, despite a potentially lower payout.
6 Apr, 16:15 — 6 Apr, 16:15
Sources
Showing 1 of 1 sources
